Startup | December 05, 2025
Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
This is the first time in history that an NDA for a New Chemical Entity (NCE) from an Indian pharmaceutical company has been filed and accepted by the USFDA
Phase one of the expansion will convert an existing hall into an ISO 7-certified cleanroom for GMP-compliant production
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
This remarkable increase from 17 in 2021 ranks among the fastest for pharmaceutical companies, establishing Lupin as a leader in sustainable growth
The successful refinancing and enhancement of the syndicated credit facilities provides access to an additional CHF 40 million
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines
Subscribe To Our Newsletter & Stay Updated
